Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Lee

Showing results (131-140 of 134) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 134 results.
Nature|April 29, 2021
Somatic mutation landscapes at single-molecule resolutionFederico Abascal, Luke M R Harvey, Emily Mitchell, et al.
Cancer Discovery|December 12, 2024
Predisposition Footprints in the Somatic Genome of Wilms TumorsTaryn D Treger, Jenny Wegert, Anna Wenger, et al.
Cancer Discovery|July 22, 2020
Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung CancerAdam Pennycuick, Vitor H Teixeira, Khalid AbdulJabbar, et al.
The Lancet. Oncology|December 14, 2024
The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational studyAnna Santarsieri, Emily Mitchell, My H Pham, et al.
Pageof 14

Showing results (131-140 of 134) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 134 results.
Nature|April 29, 2021
Somatic mutation landscapes at single-molecule resolutionFederico Abascal, Luke M R Harvey, Emily Mitchell, et al.
Cancer Discovery|December 12, 2024
Predisposition Footprints in the Somatic Genome of Wilms TumorsTaryn D Treger, Jenny Wegert, Anna Wenger, et al.
Cancer Discovery|July 22, 2020
Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung CancerAdam Pennycuick, Vitor H Teixeira, Khalid AbdulJabbar, et al.
The Lancet. Oncology|December 14, 2024
The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational studyAnna Santarsieri, Emily Mitchell, My H Pham, et al.
Pageof 14